Health
Eli Lilly's Special Access to Obesity Drug Sparks Doctor Concerns
Doctors are struggling to obtain the obesity drug retatrutide after Eli Lilly granted early access to one patient. The situation highlights ongoing issues with drug distribution and accessibility.
Coverage timeline — 1 article
STAT News
Doctors are asking how to get retatrutide for their patients, after Eli Lilly gave one man early access.
2026-08-03 17:27 UTC